Safety Study of rAAV2/8-hCYP4V2 in Patients With Bietti's Crystalline Dystrophy (BCD)
NCT04722107
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Bietti's Crystalline Dystrophy
Interventions
DRUG:
rAAV2/8-hCYP4V2
Sponsor
Beijing Tongren Hospital